Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors

被引：0
|
作者：
Igawa, Yukiko Shimoda
Yoshida, Tatsuya
Yoshinami, Yuri
Hibino, Yukiko
Arima, Takamichi
Sato, Jun
Maruki, Yuta
Shoji, Hirokazu
Namikawa, Kenjiro
Sudo, Kazuki
Honma, Yoshitaka
Hashimoto, Hironobu
Yamazaki, Naoya
Okusaka, Takuji
Yonemori, Kan
Yamamoto, Noboru
Ohe, Yuichiro
Kato, Ken
机构：
[1] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan
[3] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan
[4] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan
[5] Natl Canc Ctr, Dept Pharm, Tokyo, Japan
[6] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[7] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan
[8] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12133
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Original Research Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology
    Alouani, Emily
    Laparra, Ariane
    Perret, Audrey
    Sakkal, Madonna
    Messayke, Sabine
    Danlos, Francois-Xavier
    Ouali, Kaissa
    Hollebecque, Antoine
    Even, Caroline
    Ammari, Samy
    Baldini, Capucine
    Champiat, Stephane
    Besse, Benjamin
    Robert, Caroline
    Guettier, Catherine
    Samuel, Didier
    Lambotte, Olivier
    De Martin, Eleonora
    Michot, Jean-Marie
    EUROPEAN JOURNAL OF CANCER, 2023, 193
  • [2] Preexisting autoantibodies as predictor of immune-related adverse events for advanced solid tumors treated with immune checkpoint inhibitors
    Daban, Arthur
    Gonnin, Cecile
    Vano, Yann-Alexandre
    Phan, Letuan
    Lillo-Lelouet, Agnes
    Le Beller, Christine
    Pouchot, Jacques
    Fabre, Elizabeth
    Weiss, Laurence
    Tartour, Eric
    Oudard, Stephane
    Durey, Marie-Agnes Dragon
    Simonaggio, Audrey
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Risk of Immune-Related Pancreatitis in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors: Systematic Assessment with Meta-Analysis
    Su, Qiang
    Zhang, Xiao-chen
    Zhang, Chen-guang
    Hou, Yan-li
    Yao, Yu-xia
    Cao, Bang-wei
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [4] Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review
    Abdel-Rahman, Omar
    Oweira, Hani
    Petrausch, Ulf
    Helbling, Daniel
    Schmidt, Jan
    Mannhart, Meinrad
    Mehrabi, Arianeb
    Schoeb, Othmar
    Giryes, Anwar
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (04) : 387 - 394
  • [5] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [6] Early incidence of immune-related adverse events (irAEs) predicts efficacy in patients (pts) with solid tumors treated with immune-checkpoint inhibitors (ICIs).
    Morehouse, Chris
    Abdullah, Shaad Essa
    Gao, Chen
    Dar, Mohammed M.
    Ranade, Koustubh
    Higgs, Brandon W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] MUSCULOSKELETAL IMMUNE-RELATED ADVERSE EVENTS IN 927 PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS FOR SOLID CANCER
    Melia, A.
    Fockens, E.
    Madroszyk, A.
    Lafforgue, P.
    Pham, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 184 - 185
  • [8] Musculoskeletal immune-related adverse events in 927 patients treated with immune checkpoint inhibitors for solid cancer
    Melia, Angelique
    Fockens, Emilie
    Sfumato, Patrick
    Zemmour, Christophe
    Madroszyk, Anne
    Lafforgue, Pierre
    Pham, Thao
    JOINT BONE SPINE, 2023, 90 (01)
  • [9] Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
    Konig, David
    Laubli, Heinz
    PHARMACOLOGY, 2021, 106 (3-4) : 123 - 136
  • [10] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    Current Rheumatology Reports, 2018, 20
12345